Suresh S. Ramalingam, Executive Director of Winship Cancer Institute of Emory University, shared a post on X:
“A patient of mine on Keytruda for NSCLC had restaging scans last week.
Before I had a chance to meet the patient to discuss results, Humana insurance sent a letter to him that he has progressed and will no longer be covered for keytruda.
Has any of you encountered this?“